Chiropractors in Uncasville, CT Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dr. Jennifer Melissa Feeney, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2020 Norwich New London Tpke Unit 9, Uncasville, CT 06382 Phone: 203-470-5038 Fax: 860-892-8151 |
 Montville Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1031 Norwich New London Tpke, Suite 9, Uncasville, CT 06382 Phone: 860-848-8977 Fax: 860-848-8957 |
Greater Norwich Chiropractic, Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 2020 Norwich New London Tpke Unit 9, Uncasville, CT 06382 Phone: 203-470-5038 Fax: 860-892-8151 |
 Dr. Michael Lee Murphy, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 9 Maple Avenue Ext, Uncasville, CT 06382 Phone: 860-848-8977 Fax: 860-848-3572 |
News Archive
Cipher Pharmaceuticals to defend alleged patent infringement of CIP-TRAMADOL ER
Cipher Pharmaceuticals Inc. today announced that Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. have filed a complaint against Cipher in the United States District Court for the Eastern District of Virginia, for alleged infringement of two U.S. patents. The action relates to Cipher's New Drug Application ("NDA") filed with the U.S. Food and Drug Administration ("FDA") for CIP TRAMADOL ER, the Company's extended-release tramadol product.
Omeros' OMS302 reduces incidence of miosis during intraocular lens replacement in Phase 3 clinical trial
Omeros Corporation today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement. OMS302 is the company's proprietary Pharmacosurgery product being developed for all ILR, including cataract surgery and refractive lens exchange.
FDA grants marketing approval for CSL Behring's Berinert C1-Esterase Inhibitor
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
Republicans looking ahead with plans to dismantle health law
GOP activists, who increasingly consider both the Senate and White House to be within reach, are developing multi-pronged strategies to roll-back the health law beginning in 2013.
Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.
› Verified 2 days ago
Physical Therapists
Occupational Therapists
Chiropractors
Optometrists
Speech-Language Pathologists